AbbVie Inc.

AbbVie Inc. - PE Ratioverified

ABBV

Price:

$216.63

Market Cap:

$382.74B

AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) ...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2013-01-02

Stock Exchange

NYSE

Ticker

ABBV

The PE Ratio as of June 2026 (TTM) for AbbVie Inc. (ABBV) is 105.67

According to AbbVie Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 105.67. This represents a change of -51.12% compared to the average of 216.18 of the last 4 quarters.

AbbVie Inc. (ABBV) Historical PE Ratio (quarterly & annually)

How has ABBV PE Ratio performed in the past?

The mean historical PE Ratio of AbbVie Inc. over the last ten years is 39.97. The current 105.67 PE Ratio has changed 26.34% with respect to the historical average. Over the past ten years (40 quarters), ABBV's PE Ratio was at its highest in in the December 2020 quarter at 2.37K. The PE Ratio was at its lowest in in the December 2024 quarter at -2454.42.

Quarterly (TTM)
Annual

Average

39.97

Median

27.10

Minimum

16.71

Maximum

96.41

AbbVie Inc. (ABBV) PE Ratio by Quarter and Year

Discovering the peaks and valleys of AbbVie Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 134.94%

Maximum Annual PE Ratio = 96.41

Minimum Annual Increase = -46.76%

Minimum Annual PE Ratio = 16.71

Quarterly (TTM)
Annual
YearPE RatioChange
202596.4130.21%
202474.0430.43%
202356.77133.58%
202224.3016.31%
202120.90-46.76%
202039.25134.94%
201916.71-33.13%
201824.98-14.49%
201729.2270.30%
201617.16-8.77%

AbbVie Inc. (ABBV) Average PE Ratio

How has ABBV PE Ratio performed in the past?

The current PE Ratio of AbbVie Inc. (ABBV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

75.74

5-year avg

54.48

10-year avg

39.97

AbbVie Inc. (ABBV) PE Ratio vs. Peers

How is ABBV’s PE Ratio compared to its peers?

AbbVie Inc.’s PE Ratio is greater than Johnson & Johnson (26.34), greater than AstraZeneca PLC (25.98), greater than Novartis AG (21.02), greater than Novo Nordisk A/S (10.68), greater than Merck & Co., Inc. (31.99), greater than UnitedHealth Group Incorporated (30.24), greater than Amgen Inc. (23.31), greater than Gilead Sciences, Inc. (16.68), greater than Pfizer Inc. (19.25), greater than Sanofi (11.75),

CompanyPE RatioMarket cap
26.34$549.78B
25.98$271.29B
21.02$280.64B
10.68$191.93B
31.99$281.24B
30.24$364.13B
23.31$182.21B
16.68$153.66B
19.25$143.74B
11.75$101.89B

Build a custom stock screener for AbbVie Inc. (ABBV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbbVie Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AbbVie Inc. (ABBV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AbbVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is AbbVie Inc.'s PE Ratio?

How is the PE Ratio calculated for AbbVie Inc. (ABBV)?

What is the highest PE Ratio for AbbVie Inc. (ABBV)?

What is the 3-year average PE Ratio for AbbVie Inc. (ABBV)?

What is the 5-year average PE Ratio for AbbVie Inc. (ABBV)?

How does the current PE Ratio for AbbVie Inc. (ABBV) compare to its historical average?